|
||
Colofac Tablets 135mg Uses |
||
Irritable bowel syndrome & allied conditions eg, chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Symptomatic treatment of abdominal pain, cramps, nonspecific diarrhoea & flatulence. GI spasm secondary to organic diseases eg, diverticulitis, gastritis, duodenitis, oesophagitis, cholecystitis, Crohn's disease, ulcerative colitis, peptic ulcer, gallbladder disease, hiatus hernia, GIT inflammation.
Colofac Tablets 135mg is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Each capsule contains Colofac Tablets 135mg HCl 200 mg.
Colofac Tablets 135mg also contains the following excipients: Capsule Content (Granules): Magnesium stearate, polyacrylate dispersion 30%, talc, hypromellose, methacrylic acid-ethyl acrylate copolymer (1:1) dispersion 30% and glycerol triacetate. Capsule Shell: Gelatin, titanium dioxide (E171). Printing Ink: Shellac (E904), black iron oxide (E172), propylene glycol, concentrated ammonia solution, potassium hydroxide.
Adults: 1 capsule twice daily (1 in the morning and 1 in the evening).
Special Populations: Elderly, Renal and Hepatic Impairment: No posology studies in elderly, renal and/or hepatically impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatically impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.
Missed Dose: In case of ≥1 doses missed, continue with the next dose as prescribed; the missed doses are not to be taken in addition to the regular dose.
Administration: The capsules should be swallowed with a sufficient amount of water (at least 100 mL of water).
It should not be chewed because the coating is intended to ensure a prolonged release mechanism.
No interaction studies have been performed except with alcohol. In vitro and in vivo studies in animals have demonstrated the absence of any interaction between Colofac Tablets 135mg and ethanol.
Incompatibilities: Not applicable.
Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Just because a side effect is stated here does not mean that all people using this medicine will experience that or any side effect.
Rarely, allergic reactions such as rashes, hives, or severe swelling of lips, face or tongue (angioedema).
The side effects listed above may not include all of the side effects reported by the medicine’s manufacturer. For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.
Hypersensitivity to Colofac Tablets 135mg HCl or to any of the excipients of Colofac Tablets 135mg.
Mebeverine hydrochloride in United Kingdom.
List of Colofac Tablets 135mg substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Boots Pharmacy IBS Relief 135 mg Tablets (United Kingdom) | |
CUSPA (India) | |
135 mg x 10's (Cubit (Cucard)) | |
Cuspa 135mg TAB / 10 (Cubit (Cucard)) | |
CUSPA tab 135 mg x 10's (Cubit (Cucard)) | |
Cuspa 135mg TAB / 10 (Cubit (Cucard)) | |
Mebeverine Hydrochloride | |
MEBIZ-SR (India) | |
200 mg x 10's (Sun) | $ 1.67 |
Mebiz-SR 200mg CAP / 10 (Sun) | $ 1.67 |
MEBIZ-SR modified-release cap 200 mg x 10's (Sun) | $ 1.87 |
Mebiz-SR 200mg CAP / 10 (Sun) | $ 1.67 |
Users | % | ||
---|---|---|---|
1 day | 1 | 100.0% |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|